Fundraising FoxNeobe Therapeutics
5 known investors
Find your way into Neobe Therapeutics
Sign up to see every warm intro you have to Neobe Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neobe Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeoBe Therapeutics develops engineered live biotherapeutics for oncology, combining synthetic biology and immunology to create next-generation cell therapies. The company serves cancer patients through collaborations with leading academic institutions and investors.
Founders & leadership
Investors · 5
Also in the syndicate · 3
Cancer Research HorizonsDiscovery Park VenturesPioneer Grouplead
Funding
SEC filings, press & company announcements$2.3M disclosed across 1 round · 2024
- $2.3MraisedFeb 2024 · 2 sources
Pioneer Group (lead), 2048 Ventures, Cancer Research Horizons, Deep Science Ventures, Discovery Park Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Neobe Therapeutics do?
- NeoBe Therapeutics develops engineered live biotherapeutics for oncology, combining synthetic biology and immunology to create next-generation cell therapies. The company serves cancer patients through collaborations with leading academic institutions and investors.
- Who founded Neobe Therapeutics?
- Neobe Therapeutics was founded by Pedro Correa de Sampaio, Annelise Soulier.
- Who are Neobe Therapeutics's investors?
- Neobe Therapeutics's investors include 2048 Ventures, Deep Science Ventures.
- How much funding has Neobe Therapeutics raised?
- Neobe Therapeutics has disclosed $2.3M raised across 1 round.